Capricor Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $11,130 |
Gross Profit | -20,359 | -22,047 | -18,915 | -3,424 |
EBITDA | -24,075 | -27,232 | -24,577 | -7,322 |
EBIT | -24,570 | -27,719 | -24,982 | -7,697 |
Net Income | -24,570 | -25,910 | -24,391 | -7,116 |
Net Change In Cash | 0 | 0 | 0 | 11,130 |
Free Cash Flow | -23,698 | -21,571 | -7,573 | -15,531 |
Cash | 19,510 | 23,241 | 28,794 | 11,286 |
Basic Shares | 45,716 | 45,709 | 45,637 | 35,219 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $22,270 | $25,178 | $2,551 | $244 |
Gross Profit | -27,698 | -11,269 | -19,265 | 244 |
EBITDA | -41,139 | -23,008 | -29,164 | -20,692 |
EBIT | -42,564 | -24,077 | -29,697 | -20,938 |
Net Income | -40,467 | -22,287 | -29,019 | -20,022 |
Net Change In Cash | 22,270 | 25,178 | 2,551 | 244 |
Cost of Revenue | -25,282 | 2,219 | ||
Free Cash Flow | -41,534 | -27,644 | 1,556 | -18,005 |
Cash | 11,286 | 14,694 | 9,603 | 34,885 |
Basic Shares | 35,219 | 26,778 | 24,552 | 23,089 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.54 |
2025-06-30 | -$0.57 |
2025-03-31 | -$0.53 |
2024-12-31 | -$0.16 |
